September 24 2024 - Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar

Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Inside the GLP-1 'price war'
Novartis inks $1B-plus biobucks deal with Flagship's Generate
Eli Lilly's Alzheimer's drug approved in Japan
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*